expert roundtables by Brent P. Forester, MD, MSc, Joseph F. Goldberg, MD, Charles F. Reynolds, III, MD
While the Montreal Cognitive Assessment (MoCA) is recommended in the primary care setting as a screening tool for cognitive impairment, the optimal......READ MORE
expert roundtables by Roger McIntyre, MD, Madhukar Trivedi, MD
How much is truly known about antidepressants and cognition, and are strategies for selecting antidepressants formulated with careful consideration......READ MORE
expert roundtables by Charles Debattista, MD, Roger McIntyre, MD, Madhukar Trivedi, MD
How feasible would it be to implement a point-of-care screening tool, or symptom-monitoring tool, to measure cognition in depressed patients? While......READ MORE
expert roundtables by Charles Debattista, MD, Ira D. Glick, MD, Roger McIntyre, MD, Madhukar Trivedi, MD
For elderly patients with major depressive disorder (MDD), the same set of principles for assessing cognition in depression should continue to appl......READ MORE
expert roundtables by Ira D. Glick, MD, Roger McIntyre, MD, Madhukar Trivedi, MD
Newer molecular entities are actively being researched as candidates for novel antidepressant therapies. Additionally, new insights on established ......READ MORE
expert roundtables by Charles Debattista, MD, Roger McIntyre, MD, Madhukar Trivedi, MD
It has been known for decades that residual symptoms of major depressive disorder (MDD) are associated with an increased risk of relapse and with d......READ MORE
